Type 1
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study (NCT01973920) | Oshadi Drug Administration | 2013-12-01 |
Track Type 1 automatically
Every clearance here is in the API, with alerts when new ones post.